MCK (NYSE) - McKesson Corporation

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for MCK (NYSE) - McKesson Corporation


Market Cap in USD 56,744m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1994-11-15


Fundamental 5.79
Dividend 6.01
Performance 5y 8.87
Rel. Performance vs Sector 1.92
Analysts 4.31
Fair Price Total Ret. 495.13
Fair Price DCF todo


Growth TTM 27.89%
CAGR 5y 28.06%
CAGR / Mean Drawdown 5y 4.79
Sharpe Ratio TTM 1.05
Alpha vs SP500 TTM 13.44
Beta vs SP500 5y weekly 0.73
CAPM 6.94%
Average Daily Range 2m 1.64%
Reversal Oscillator 66.23
Volatility GJR Garch 1y 23.25%
Price / SMA 50 2.79%
Price / SMA 200 12.26%
Current Volume 679.1k
Average Volume 20d 750k


Yield TTM 0.52%
Yield on Cost 5y 1.77%
Dividends CAGR 5y 6.71%
Consistency of Dividends all time 97.3%